Very excited to be part of team SAMBAI. This represents the largest single NCI/CRUK award for cancer inequities ever. For @YemaachiBio to be one of 2 African partners (and the only biotech) responsible for centering large part of this work in Africa is both humbling and exciting.
Human Infection Studies conducted in endemic settings allow for vaccines to be tailored for those most affected. Have a listen to this podcast about the Pneumococcus Human Infection Study funded through the Wellcome Programme in Malawi.
@MichaelWKChew@wellcometrust And if does not work as hoped, community involvement,trial capacity & ownership Africa & Asia,trial design, data, investment allied social science, Dx,transmission,epidemiology, immunology,pathogen biology, economics can catalyse funding & hope in this awful & neglected infection
🏆 Congratulations to our next #NHMRCAwards recipient, Professor Wai-Hong Tham (@tham_lab), Head of the Infectious Diseases and Immune Defence Division at @WEHI_research who has received the 2022 Elizabeth Blackburn Investigator Grant Award - Basic Science (Leadership).
5 advances in fighting malaria
💊 Antimalarial drugs to treat and prevent malaria infection
☁️ Insecticides to reduce disease transmission
🌿 Artemisinin drugs to treat highly drug-resistant strains of malaria
⛺ Bed nets to block mosquitoes from biting
💉 Vaccines to save lives
Have you viewed our library which has been developed to support global #malaria research efforts. The library is a compilation of 1,278 published clinical efficacy studies from 1946 to 2020
https://t.co/OQltdYkzJZ
We have had no meaningful increase in @NHMRC investment for over a decade. Outstanding science is going unfunded and we are losing world-leading scientists.
We call on both sides of politics to support the sector & commit to doubling the NHMRC budget #auspol